Disposition of gamithromycin in plasma, pulmonary epithelial lining fluid, bronchoalveolar cells, and lung tissue in cattle
- 1 March 2011
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 72 (3) , 326-330
- https://doi.org/10.2460/ajvr.72.3.326
Abstract
Objective—To determine the disposition of gamithromycin in plasma, pulmonary epithelial lining fluid (PELF), bronchoalveolar lavage (BAL) cells, and lung tissue homogenate in cattle. Animals—33 healthy Angus calves approximately 7 to 8 months of age. Procedures—Calves were randomly assigned to 1 of 11 groups consisting of 3 calves each, which differed with respect to sample collection times. In 10 groups, 1 dose of gamithromycin (6 mg/kg) was administered SC in the neck of each calf (0 hours). The remaining 3 calves were not treated. Gamithromycin concentrations in plasma, PELF, lung tissue homogenate, and BAL cells (matrix) were measured at various points by means of high-performance liquid chromatography with tandem mass spectrometry. Results—Time to maximum gamithromycin concentration was achieved at 1 hour for plasma, 12 hours for lung tissue, and 24 hours for PELF and BAL cells. Maximum gamithromycin concentration was 27.8 μg/g, 17.8 μg/mL, 4.61 μg/mL, and 0.433 μg/mL in lung tissue, BAL cells, PELF, and plasma, respectively. Terminal half-life was longer in BAL cells (125.0 hours) than in lung tissue (93.0 hours), plasma (62.0 hours), and PELF (50.6 hours). The ratio of matrix to plasma concentrations ranged between 4.7 and 127 for PELF, 16 and 650 for lung tissue, and 3.2 and 2,135 for BAL cells. Conclusions and Clinical Relevance—Gamithromycin was rapidly absorbed after SC administration. Potentially therapeutic concentrations were achieved in PELF, BAL cells, and lung tissue within 30 minutes after administration and persisted for 7 (PELF) to > 15 (BAL cells and lung tissue) days after administration of a single dose.Keywords
This publication has 18 references indexed in Scilit:
- Pharmacokinetics of gamithromycin in cattle with comparison of plasma and lung tissue concentrations and plasma antibacterial activityJournal of Veterinary Pharmacology and Therapeutics, 2009
- Susceptibility testing of tulathromycin: Interpretative breakpoints and susceptibility of field isolatesVeterinary Microbiology, 2008
- Infection Site Concentrations: Their Therapeutic Importance and the Macrolide and Macrolide-Like Class of AntibioticsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- The determination of the cellular volume of avian, porcine and bovine phagocytes and bovine mammary epithelial cells and its relationship to uptake of tilmicosinJournal of Veterinary Pharmacology and Therapeutics, 1999
- Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattleJournal of Veterinary Pharmacology and Therapeutics, 1998
- Efficacy of tilmicosin in the control of experimental Mycoplasma gallisepticum infection in chickens.Published by JSTOR ,1997
- Minimum Inhibitory Concentration Breakpoints and Disk Diffusion Inhibitory Zone Interpretive Criteria for Tilmicosin Susceptibility Testing against Pasteurella Spp. Associated with Bovine Respiratory DiseaseJournal of Veterinary Diagnostic Investigation, 1996
- Pulmonary disposition of antimicrobial agents: methodological considerationsAntimicrobial Agents and Chemotherapy, 1992
- Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection responseAntimicrobial Agents and Chemotherapy, 1991
- Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilutionJournal of Applied Physiology, 1986